Trials / Conditions / Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8

Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8

9 registered clinical trials studyying Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno NCT05041153	M.D. Anderson Cancer Center	EARLY_Phase 1
Recruiting	Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv NCT04660760	Academic and Community Cancer Research United	Phase 2
Active Not Recruiting	Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events NCT05038254	M.D. Anderson Cancer Center	N/A
Recruiting	PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorecta NCT04329494	City of Hope Medical Center	Phase 1
Recruiting	Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893	University of California, San Francisco	N/A
Active Not Recruiting	Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer NCT04220827	M.D. Anderson Cancer Center	Phase 1
Completed	IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga NCT03918499	City of Hope Medical Center	Phase 1 / Phase 2
Recruiting	Intravital Microscopy in Human Solid Tumors NCT03823144	Mayo Clinic	N/A
Completed	Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma NCT03395847	M.D. Anderson Cancer Center	EARLY_Phase 1